Sigma Planning Corp Medpace Holdings, Inc. Transaction History

Sigma Planning Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 31, 2020	SELL	$68.08 - $95.68 $274,022 - $385,112	-4,025 Closed	0 $0
Q1 2020 May 01, 2020	BUY	$61.71 - $101.95 $1,913 - $3,160	31 Added 0.78%	4,025 $295,000
Q4 2019 Feb 03, 2020	SELL	$70.08 - $84.64 $140 - $169	-2 Reduced 0.05%	3,994 $336,000
Q3 2019 Nov 01, 2019	SELL	$62.38 - $85.89 $41,981 - $57,803	-673 Reduced 14.41%	3,996 $336,000
Q2 2019 Aug 01, 2019	BUY	$53.64 - $65.42 $250,445 - $305,445	4,669 New	4,669 $305,000

654

25.6M

38.7K

79.5K

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $10.4B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

Get notified when there are updates to the investment portfolio of Sigma Planning Corp, based on Form 13F filings with the SEC.

Stay updated on Sigma Planning Corp with notifications on news.